Day One Biopharmaceuticals, Inc. (DAWN) Financials
Stock symbol DAWN is outdated, potentially delisted? Maybe it is available on other exchange?
DAWN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 507.8 million | 66.7 million |
| Sept. 30, 2025 | 513.8 million | 62.9 million |
| June 30, 2025 | 519.0 million | 58.2 million |
| March 31, 2025 | 534.4 million | 54.8 million |
DAWN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -17.6 million | 11.1 million |
| Sept. 30, 2025 | -5.8 million | 9.6 million |
| June 30, 2025 | -21.3 million | 10.9 million |
| March 31, 2025 | -62.8 million | 12.9 million |
DAWN Net Income
No data available :(
DAWN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 441.1 million | 2.6 million | 2.8 million |
| Sept. 30, 2025 | 451.6 million | - | 2.7 million |
| June 30, 2025 | 453.1 million | - | 2.9 million |
| March 31, 2025 | 473.0 million | - | 2.9 million |
DAWN Shares Outstanding
DAWN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 3.5 million | 40.9 million | 34.1 million | - |
| Sept. 30, 2025 | 3.8 million | 31.4 million | 28.1 million | - |
| June 30, 2025 | 3.5 million | 36.1 million | 29.0 million | - |
| March 31, 2025 | 3.8 million | 39.6 million | 29.3 million | - |
DAWN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 53.7 million | 6.1 million |
| Sept. 30, 2025 | 39.8 million | 4.5 million |
| June 30, 2025 | 33.9 million | 3.8 million |
| March 31, 2025 | 30.8 million | 2.9 million |
DAWN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
DAWN
Price: $21.53
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 433900
Market Capitalization: 2.2 billion